Caris Life Sciences (CAI) Interest & Investment Income (2024 - 2026)

Caris Life Sciences' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $6.8 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 1258.65% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $22.8 million (up 289.74% YoY), while the FY2025 annual figure was $16.5 million, up 131.63% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $6.8 million, down from $7.0 million in the prior quarter.
• The five-year high for Interest & Investment Income was $7.4 million in Q3 2025, with the low at $503000.0 in Q1 2025.
• The 3-year median for Interest & Investment Income is $2.2 million (2024), against an average of $3.6 million.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income slumped 38.71% in 2025, then soared 1258.65% in 2026.
• Caris Life Sciences' Interest & Investment Income stood at $970000.0 in 2024, then soared by 623.2% to $7.0 million in 2025, then retreated by 2.58% to $6.8 million in 2026.
• Business Quant data shows CAI's Interest & Investment Income at $6.8 million in Q1 2026, $7.0 million in Q4 2025, and $7.4 million in Q3 2025.